Tenofovir Df + Emtricitabine + Elvitegravir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Oral tablet (film-coated)
Available Strengths: Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg
Reference Brands: Stribild (US & EU)
Category: Anti Viral
Stribild is a once-daily HIV-1 treatment combining TDF, Emtricitabine, Elvitegravir, and Cobicistat in one tablet. FDA and EMA approved, it provides effective viral suppression and improved adherence. Must be taken with food. Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat is available in Oral tablet (film-coated) and strengths such as Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tenofovir DF + Emtricitabine + Elvitegravir + Cobicistat can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Tenofovir Disoproxil Fumarate (TDF) + Emtricitabine + Elvitegravir + Cobicistat, marketed as Stribild, is a complete, once-daily, single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults and adolescents. This fixed-dose combination includes an integrase inhibitor (Elvitegravir), two NRTIs (TDF and Emtricitabine), and a pharmacokinetic booster (Cobicistat). Approved by the US FDA and EMA, Stribild offers strong viral suppression and improved patient adherence by reducing pill burden. It must be taken with food to ensure optimal absorption. Stribild is widely used in global HIV programs, though newer TAF-based regimens like Genvoya offer improved renal and bone safety.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir DF, Emtricitabine, Elvitegravir, and Cobicistat are combined to treat human immunodeficiency virus (HIV-1) infection. This fixed-dose combination helps reduce the amount of HIV in the body, maintains immune function, and lowers the risk of developing HIV-related complications.
This combination contains four active antiretroviral ingredients: Tenofovir Disoproxil Fumarate (a nucleotide reverse transcriptase inhibitor), Emtricitabine (a nucleoside reverse transcriptase inhibitor), Elvitegravir (an integrase strand transfer inhibitor), and Cobicistat (a pharmacokinetic enhancer that increases Elvitegravir levels by inhibiting CYP3A enzymes).
The main trade name for this fixed-dose combination is Stribild.
Stribild is manufactured by Gilead Sciences, Inc.
The generic name is Tenofovir Disoproxil Fumarate, Emtricitabine, Elvitegravir, and Cobicistat.
The brand name is Stribild.
Stribild and its generic versions are manufactured in the United States by Gilead Sciences and by WHO-GMP-approved facilities in India and other countries for global distribution.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
